Aptalis Pharmaceutical Technologies, a business unit of Aptalis Pharma, has announced its co-sponsorship of Controlled Release Society's Young Investigator Award and its participation in the thirty-ninth Annual Meeting & Exposition of the Controlled Release Society (CRS) 15 – 18 July 2012 in Quebec City, Canada.
Aptalis Pharmaceutical Technologies and the Controlled Release Society recognized Cory Berkland as the recipient of the 2012 CRS Young Investigator Award at the Society's Annual Meeting & Exposition.
Professor Berkland, a co-founder of Orbis Biosciences and Savara Pharmaceuticals, is a professor in the Department of Chemical and Petroleum Engineering and in the Department of Pharmaceutical Chemistry at the University of Kansas, US. Dr. Berkland' lab studies colloids, polymers, and biomaterials.
A CRS member, who has made outstanding contributions in the science of controlled release, and be 40 years of age or younger on 31 December 2011, will be recognized for young investigator's award.
